In this review, we focused on the updated information on CD8+ T cells in MG/EAMG, as well as on the relevant evidence (peripheral, in situ, CSF, and under different conditions), in vitro culture, TCR usage, cytokine and chemokine expression, cell marker expression, Tregs, and Tc17. This evidence concerns the gene CD8A and myasthenia gravis.